KEROS THERAPEUTICS INC

Ticker: KROS CUSIP: 492327101 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 472,520 Value ($000) $9,621 Avg Close $17.54 Range $13.60 - $22.55
Q3 2025
Shares 176,144 Value ($000) $2,787 Avg Close $14.77 Range $13.13 - $16.30
Q2 2025
Shares 22,898 Value ($000) $306 Avg Close $13.50 Range $9.12 - $15.40
Q1 2025
Shares 191,609 Value ($000) $1,952 Avg Close $11.61 Range $9.71 - $16.70
Q4 2024
Shares 791,109 Value ($000) $12,523 Avg Close $51.97 Range $15.33 - $72.37
Q3 2024
Shares 704,923 Value ($000) $40,935 Avg Close $49.39 Range $40.93 - $59.06
Q2 2024
Shares 410,484 Value ($000) $18,759 Avg Close $53.73 Range $43.30 - $67.30
Q1 2024
Shares 450,278 Value ($000) $29,808 Avg Close $59.30 Range $39.00 - $73.00
Q4 2023
Shares 760,168 Value ($000) $30,224 Avg Close $31.36 Range $27.02 - $41.92
Q3 2023
Shares 405,149 Value ($000) $12,916 Avg Close $37.33 Range $31.17 - $44.95
Q2 2023
Shares 327,800 Value ($000) $13,171 Avg Close $43.84 Range $37.03 - $51.16
Q1 2023
Shares 371,483 Value ($000) $15,862 Avg Close $50.51 Range $39.98 - $59.96
Q4 2022
Shares 405,471 Value ($000) $19,471 Avg Close $46.71 Range $37.40 - $52.78
Q3 2022
Shares 428,107 Value ($000) $16,106 Avg Close $34.66 Range $26.34 - $42.15
Q2 2022
Shares 354,354 Value ($000) $9,791 Avg Close $43.88 Range $24.38 - $68.29
Q1 2022
Shares 280,161 Value ($000) $15,235 Avg Close $51.33 Range $39.75 - $60.42
Q4 2021
Shares 277,102 Value ($000) $16,213 Avg Close $49.87 Range $36.13 - $63.47
Q3 2021
Shares 274,325 Value ($000) $10,852 Avg Close $35.59 Range $28.50 - $44.87
Q2 2021
Shares 117,948 Value ($000) $5,009 Avg Close $54.17 Range $41.88 - $71.74
Q1 2021
Shares 127,925 Value ($000) $7,873 Avg Close $63.36 Range $51.48 - $75.99
Q4 2020
Shares 269,243 Value ($000) $18,992 Avg Close $63.02 Range $34.17 - $88.80
Q2 2020
Shares 157,333 Value ($000) $5,901 Avg Close $30.81 Range $19.10 - $42.26